TRIM6 affects the prognosis of acute myeloid leukemia through the PI3K/AKT signaling pathway and is associated with immune infiltration

• Jingxin Zhang ,

  Contributed equally to this work with: Jingxin Zhang, Wu Zhou

  Roles Data curation, Methodology, Resources, Software, Validation, Writing – original draft

  Affiliation Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

  ⨯
• Wu Zhou ,

  Contributed equally to this work with: Jingxin Zhang, Wu Zhou

  Roles Methodology, Software, Supervision

  Affiliation Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

  ⨯
• Yuancheng Liu,

  Roles Investigation

  Affiliation Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

  ⨯
• Chenglong Hu,

  Roles Software

  Affiliation Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

  ⨯
• Siqi Wang,

  Roles Methodology, Project administration, Supervision

  Affiliation Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

  ⨯
• Jianxia Xu,

  Roles Software, Visualization

  Affiliation Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

  ⨯
• Sixi Wei

  Roles Funding acquisition, Supervision, Writing – review & editing

  * E-mail: Weisixi111@163.com

  Affiliations Department of Clinical Biochemistry, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou, China, Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China

  https://orcid.org/0009-0009-5210-5385

  ⨯